The fredericamycin (FDM) A biosynthetic gene cluster, cloned previously from Streptomyces griseus ATCC 49344, contains three putative regulatory genes, fdmR, fdmR1, and fdmR2. Their deduced gene products show high similarity to members of the Streptomyces antibiotic regulatory protein (SARP) family (FdmR1) or to MarR-like regulators (FdmR and FdmR2). Here we provide experimental data supporting FdmR1 as a SARP-type activator. Inactivation of fdmR1 abolished FDM biosynthesis, and FDM production could be restored to the fdmR1::aac(3)IV mutant by expressing fdmR1 in trans. Reverse transcription-PCR transcriptional analyses revealed that up to 26 of the 28 genes within the fdm gene cluster, with the exception of fdmR and fdmT2, were under the positive control of FdmR1, directly or indirectly. Overexpression of fdmR1 in S. griseus improved the FDM titer 5.6-fold (to about 1.36 g/liter) relative to that of wild-type S. griseus. Cloning of the complete fdm cluster into an integrative plasmid and subsequent expression in heterologous hosts revealed that considerable amounts of FDMs could be produced in Streptomyces albus but not in Streptomyces lividans. However, the S. lividans host could be engineered to produce FDMs via constitutive expression of fdmR1; FDM production in S. lividans could be enhanced further by overexpressing fdmC, encoding a putative ketoreductase, concomitantly with fdmR1. Taken together, these studies demonstrate the viability of engineering FDM biosynthesis and improving FDM titers in both the native producer S. griseus and heterologous hosts, such as S. albus and S. lividans. The approach taken capitalizes on FdmR1, a key activator of the FDM biosynthetic machinery.Members of the genus Streptomyces are gram-positive filamentous bacteria that continue to be a prolific source of bioactive secondary metabolites, including many clinically important antimicrobial and anticancer drugs as well as agents with agricultural or veterinary applications (7). These metabolites are predominantly products of complex biosynthetic pathways, typically activated in a growth-phase-dependent manner coinciding with the formation of aerial mycelia in solid media or confining to stationary phase in liquid cultures. The production of these natural products is often controlled by subtle and precise regulatory systems (6). A fundamental comprehension of these regulatory systems is undoubtedly helpful in understanding biosynthetic transformations, thereby enhancing opportunities for combinatorial biosynthesis to afford new compounds, and in optimizing metabolite titers in a strategic manner.Recently, heterologous expression has emerged as a powerful tool to investigate secondary metabolite biosynthetic pathways. This approach is especially advantageous for those clusters from organisms recalcitrant to genetic manipulations or resistant to effective culturing within a laboratory setting. The successful heterologous expression of defined biosynthetic pathways calls for knowledge of large gene cluster transfer, special precurs...